Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

Bridging Subjective and Objective Evaluations in Knee Osteoarthritis: The Role of the WOMAC Index

Introduction

Knee osteoarthritis is a common, often debilitating condition that affects millions of people around the world. It brings pain, stiffness, and reduced mobility, making everyday tasks like walking, climbing stairs, or even getting up from a chair much harder. For both patients and healthcare providers, tracking the progression of osteoarthritis and gauging the effectiveness of treatments is crucial. That’s where reliable assessment tools come in. Among the most widely used is the Western Ontario and McMaster Universities Osteoarthritis Index—or WOMAC. This article explores how the WOMAC index bridges the gap between how patients feel and what clinical tests show, giving everyone a clearer picture of knee osteoarthritis.

What Is the WOMAC Index?

The WOMAC index is a questionnaire developed specifically for people with knee or hip osteoarthritis. Created by researchers at Western Ontario and McMaster Universities, it focuses on three key areas that really matter in daily life:

  • Pain: How much discomfort someone feels during activities like walking or using stairs.
  • Stiffness: How stiff the joint feels, especially after periods of rest.
  • Physical Function: How easily everyday tasks—such as getting dressed, standing up, or going shopping—can be performed.

Patients simply answer questions about their symptoms and how these symptoms affect their daily lives. Thanks to advances in technology, the questionnaire can now often be filled out electronically, even from home. This allows healthcare providers to monitor symptoms more regularly and conveniently, leading to better, more responsive care.

To ensure the WOMAC’s accuracy for people in different countries and cultures, researchers have worked to adapt and validate it for a variety of populations. Shorter, streamlined versions have also been shown to offer practical, valid alternatives to the full questionnaire, particularly for people recovering from joint replacement . Recent research is also exploring how WOMAC can be adapted for patient preference studies, helping doctors tailor care that reflects what matters most to each individual.

Subjective Experiences versus Objective Measurements

Understanding knee osteoarthritis requires looking at both subjective and objective data. Subjective assessments like the WOMAC capture a person’s unique, personal experience with pain and disability—things that can’t always be measured with a machine. However, these self-reports can sometimes be affected by mood, stress, or how the questions are interpreted.

In contrast, objective measurements come from clinical tests like gait analysis, measurements of joint movement, or imaging studies like X-rays. These give concrete data about the knee’s physical state, but don’t always reflect how the person is feeling or functioning day to day.

Studies show that WOMAC scores often mirror findings from clinical tests: higher pain scores usually go hand in hand with poorer performance in objective measures. Still, there are exceptions—some people may report high pain yet do well in physical tasks, while others might feel fine but have poor test results. That’s why it’s so important to combine both kinds of information. Streamlined versions of the WOMAC also appear to capture patient experience effectively, making them valuable alternatives in busy clinical settings.

Importantly, well-adapted WOMAC measures resonate with patients as they consider their treatment options, providing a structure for them to express what matters most in daily life and in their healthcare decisions.

How the WOMAC Index Helps in Managing Knee Osteoarthritis

For doctors, therapists, and patients, the WOMAC index is an essential tool. By regularly completing this questionnaire, patients and their healthcare teams can keep an eye on how symptoms change over time. This helps everyone see whether treatments—such as physical therapy, medications, or lifestyle changes—are making a difference, and whether any adjustments are needed.

Because the WOMAC relies on self-report, there are some limitations. Answers can change depending on how someone feels that day, or how they interpret the questions. This is why combining WOMAC results with objective measurements provides a more balanced, accurate perspective. Together, these tools allow for personalized treatment plans that reflect each person’s unique experience and underlying physical condition.

Recent research shows that patients not only value improvements in pain and function, but are also able to prioritize one over the other according to what matters most to them, highlighting the importance of personalized care in knee osteoarthritis.

Looking Ahead: The Future of WOMAC and Digital Health

Digital health is changing how the WOMAC index is used. Now, thanks to telemedicine and smartphone apps, patients can easily fill out the questionnaire from home—even multiple times a week if needed. This steady stream of information allows clinicians to spot early changes, respond quickly, and engage patients more actively in managing their condition.

These innovations do more than just make data collection easier—they help patients take a bigger role in their care, encourage ongoing communication, and can lead to better outcomes. As digital tools continue to evolve, linking electronic WOMAC results with objective clinical data has the potential to transform knee osteoarthritis management for the better.

Conclusion

The WOMAC index is a powerful tool that connects patients’ personal experiences—pain, stiffness, and function—with the objective measurements doctors and therapists use. By combining both types of information, healthcare teams can see the full picture of knee osteoarthritis, supporting more personalized and effective treatment that can improve quality of life. As digital technology advances, the WOMAC index is becoming even more useful, paving the way for ongoing, real-time monitoring that benefits patients and healthcare providers alike.

References

Guermazi, M., Poiraudeau, S., Yahia, M., Mezganni, M., Fermanian, J., Elleuch, M.H., & Revel, M. (2004). Translation, adaptation and validation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) for an Arab population: the Sfax modified WOMAC. Osteoarthritis and Cartilage, 12(6), 459-468. https://doi.org/10.1016/j.joca.2004.02.006
Whitehouse, S. L., Lingard, E. A., Katz, J. N., & Learmonth, I. D. (2003). Development and testing of a reduced WOMAC function scale. Journal of Bone and Joint Surgery – British Volume, 85-B(5), 706-711.
Rosenberg, S. S., Ng, X., Mansfield, C., Poulos, C., Peay, H. L., Lee, T.-H., Irony, T., & Ho, M. (2023). Adaptation of the WOMAC for use in a patient preference study. Therapeutic Innovation & Regulatory Science, 57(4), 702-711. https://doi.org/10.1007/s43441-023-00510-8

Navigating ICD-10 Nuances in Primary Osteoarthritis of the Left Knee: A Clinical and Research Perspective

This article explores the importance of accurate ICD-10 coding for primary osteoarthritis of the left knee, highlighting its role in precise diagnosis, treatment planning, and research. It discusses challenges in distinguishing primary from secondary osteoarthritis, the impact of coding errors on patient care and data integrity, and the need for ongoing clinician education. Accurate coding enhances treatment effectiveness, aids fall prevention, and supports the development of personalized therapies. Advances in imaging, patient-reported outcomes, and upcoming ICD-11 updates promise improved disease tracking and management, ultimately improving patient outcomes and healthcare efficiency.

Read More »

Targeted Relief for Meniscus-Deficient Knees: How Arthrosamid® Helps Ease Post-Meniscectomy Osteoarthritis Symptoms

Arthrosamid® is a novel single-injection polyacrylamide hydrogel designed to relieve post-meniscectomy osteoarthritis knee pain by cushioning and stabilizing the joint. Unlike traditional treatments providing temporary relief, Arthrosamid® integrates into the synovial membrane, reducing bone-on-bone contact and enhancing knee function. Clinical studies show significant pain reduction and improved mobility lasting up to two years, especially in patients under 70 with moderate OA and normal BMI. The treatment is minimally invasive, well-tolerated, and may delay or prevent the need for surgery. Arthrosamid® offers a promising alternative to hyaluronic acid injections with longer-lasting effects, marking a breakthrough in managing post-meniscectomy knee osteoarthritis.

Read More »